EP0112356A1 - Fluid communication device. - Google Patents
Fluid communication device.Info
- Publication number
- EP0112356A1 EP0112356A1 EP83902012A EP83902012A EP0112356A1 EP 0112356 A1 EP0112356 A1 EP 0112356A1 EP 83902012 A EP83902012 A EP 83902012A EP 83902012 A EP83902012 A EP 83902012A EP 0112356 A1 EP0112356 A1 EP 0112356A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- fluid
- pump
- tubing segments
- lines
- closure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/002—Compounding apparatus specially for enteral or parenteral nutritive solutions
Definitions
- the present invention pertains to a fluid communication device for mixing and transferring solutions. More particularly, it pertains to a device especially useful in high speed compounding of hyperalimentation solutions.
- Hyperalimentation therapy is the intravenous feeding of, for example, a protein-carbohydrate mixture to a patient. It is used primarily to meet the patient's protein and caloric require- ments which are unable to be satisfied by oral feeding.
- the protein may be in the form of free- a ino acids or protein hydrolysate and the carbo ⁇ hydrate commonly is dextrose.
- vitamins water-soluble and fat-soluble
- electrolytes also can be sup ⁇ plied in this therapy.
- each of these parenteral ingredients and the combination thereof are particularly susceptible to the growth of deleterious organisms and it is desirable that they be administered to the patient in a sterile condition.
- these pro ⁇ tein and carbohydrate solutions cannot be pre-com- pounded by the manufacturer, but * must be combined at the time of their use, their compounding must be performed under sterile conditions to avoid organism growth.
- a known apparatus and process for compounding hyperalimentation solutions utilizes a solution transfer system including a receiving container and a Y-transfer set.
- the Y-transfer set includes two separate tubes, each having an end attached to a common juncture by which solutions delivered through the tubes will pass through the juncture into the receiving container.
- the other end of one tube of the set is attached to the protein holding container and of the other tube of the set to the carbohydrate holding container.
- the de ⁇ sired volume of each solution being transferred to the container is controlled by a clamp placed on each tube.
- the solutions may be allowed to flow into the receiving container by gravity flow.
- Laminar flow hoods are used for reducing the risk of airborne contamina ⁇ tion of such solutions. These units operate by taking room air and passing it through a pre-fil- ter to remove gross contaminates, such as dust and lint. The air is then compressed and channeled through a bacterial retentive filter in the hood in a laminar flow fashion. The purified air flows out over the entire work surface of the hood in parallel lines at a uniform velocity.
- the bacte- rial retentive type of filter is designed to re ⁇ move all bacteria from the air being filtered.
- the device of the present invention provides a unitized, sterile, quick and economical fluid path to be used with the aforementioned HIGH SPEED BULK COMPOUNDER. Also, the device is arranged to provide proper orientation with respect to the compounding apparatus.
- a device for fluid communication is provided to be used with an apparatus for compounding a plurality of solutions, preferably under sterile condi ⁇ tions.
- the device of the present invention in ⁇ cludes a plurality of fluid container connectors
- each container containing a solution to be compounded.
- Fluid lines sealingly connect each container connector to a respective inlet pump fitting for providing fluid flow from the solution containers to a respective pump tube.
- the pump tubes are elastomeric bodies fluidly connecting respective inlet pump fittings to exit pump fittings.
- the pump fittings include grips about their periphery to facilitate putting the pump tubes in tension about pump rollers of peri ⁇ staltic pumps of the compounder. Tension of the pump tubes is maintained by placing the pump fit ⁇ tings in respective inlets and exits provided in the housing of the compounder.
- the exit pump fittings are sealingly connect ⁇ ed to further fluid lines to provide a fluid path to a common junction block.
- the junction block separately receives each of the plurality of fur- ther fluid lines in a substantially parallel, ver ⁇ tically spaced manner so as not to inhibit fluid flow by crimping of the lines.
- the common junction block provides an exit port for sealingly and sterilely receiving a fur- ther fluid connector to provide a path to a re ⁇ ceiving container.
- the exit port is preferably at right angles to the entrance of the plurality of further fluid lines.
- the common junction block also has a closure member associated therewith to cover the exit port and protect it from contamination when not in use.
- the closure member includes a retaining ring, securing the member to the block, connected to a closure by a flexible member. In the block use or uncovered position, the ring, flexible
- OMPI member and closure lie in a substantially common plane with the internal side of the closure facing downward to prevent collecton of particulate con ⁇ tamination on the interior thereof.
- the flexible member In the block non-use or covered position, the flexible member is rotated to allow the interior of the closure to cover the exit port.
- each set of inlet and exit pump fit ⁇ tings are color or numerically coded to correspond to a respective pump of the compounder to provide proper orientation of the present invention with respect to the compounder.
- the fluid lines are sized to provide the exact requirements of length for the compounder.
- the de- vice is constructed to accommodate three solutions to be compounded.
- the device of the present in ⁇ vention provides a sterile, unitized, economical fluid path between solution containers containing solutions to be compounded and a receiving con- tainer.
- Fig. 1 is a perspective view of the present invention in accordance with its use as providing a fluid path
- Fig. 2 is a perspective view configured in accordance with the present invention
- Fig. 3 is a sectional view of a portion of the present invention.
- Fig. 4 is a sectional view of another portion of the present invention.
- a fluid com ⁇ munication device 10 of the present invention is best illustrated.
- Fig. 1 shows the device 10 in position for use with the HIGH SPEED BULK COM- POUNDER
- Fig. 2 shows the device 10 as it is removed from its sterile package.
- Supply contain ⁇ ers 12, 14 and 16, shown in phantom in Fig. 1 are fluidly connected with a receiving container 18 (also shown in phantom) by device 10.
- the supply and receiving containers which are shown in phan ⁇ tom may be flexible plastic bags of the type mar ⁇ keted by Travenol Laboratories, Inc. of Deerfield, Illinois under the registered trademark VIAFLEX.
- the device 10 provides a sterile fluid path from each supply container to a common junction block 20, where a receiving container can be placed in fluid communication therewith.
- the so ⁇ lutions to be compounded are transferred from the supply containers to the receiving container by peristaltic pumps 22, 24 and 26 (shown in phan ⁇ tom).
- the peristaltic pumps 22, 24 and 26 effect fluid flow from the supply containers 12, 14 and 16 through the device 10 to the receiving contain ⁇ er 18 by movement of rotatable rollers 28 of each pump which compress respective tensioned wall por ⁇ tions 30, 30' or 30" of the fluid path in contact therewith, forcing the fluid therein forward.
- the portion 30, 30' and 30" of the fluid paths of device 10 in contact with each respective pump is an elastomeric body or pump tubing from about four inches to about six inches long, pre ⁇ ferably five inches long, capable of being put in tension.
- the ends of each pump tubing 30, 30' and 30" are connected to respective inlet and exit pump fittings 32, 32" and 32" and 34, 34* and 34" respectively, which are operatively fixed in posi ⁇ tion to maintain the pump tubing in tension, such as placed within inlet and exit slots of a pump housing (not shown).
- the fluid paths of device 10 start with fluid connectors 36, 36' and 36".
- the tips of the fluid connectors 36, 36' and 36" are adapted to be in- serted into the supply containers 12, 14 and 16 respectively and prior to their use are covered with a protective sheath 38, 38* and 38" (Fig. 2) to prevent contamination of the connectors and the fluid paths.
- Each fluid connector is sealingly connected to a respective fluid line 40, 40* and 40", such as vinyl tubing or the like which are sealingly connected to a respective inlet pump fitting 32, 32* and 32".
- Further fluid lines 42, 42* and 42" are each sealingly connected to a re- spective exit pump fitting 34, 34' and 34" to con ⁇ nect it with the common junction block 20.
- the inlet and exit pump fittings 32 and 34 as seen in Fig. 4 are representative of like fittings and tubings of device 10.
- the inlet and exit pump fittings have a ribbed portion 43 around their periphery. This ribbed portion 43 facilitates their gripping to place pump tubing 30 in tension around rollers 28.
- the inlet and exit pump fit ⁇ tings 32 and 34 are identical and have a dish shaped portion 44 at one end connected to a cylin ⁇ drical portion 46 at the other end providing a shoulder portion 47.
- the shoulder portion 47 bears against the inlet or exit slots of the pump housing to maintain tension in the pump tubing 30 connected thereto.
- the pump tubing 30 is stretch-
- the cylindrical portion 46 includes a cy ⁇ lindrical fluid line receiver 48 tapered along its length therein having a shoulder portion 50.
- the fluid line is inserted into the cylindrical por ⁇ tion 46 through the dish shaped portion 44 until it contacts the shoulder 50.
- the line is then sealed therein.
- the cylindrical portion 46 then provides fluid communication through a hollow cy ⁇ lindrical portion 52.
- the fluid lines 40, 40' and 40" coupling re ⁇ spective fluid connectors 36, 36' and 36" to re ⁇ spective inlet pump fittings 32, 32' and 32" are preferably of the same length.
- the fluid lines 40, 40' and 40" coupling re ⁇ spective fluid connectors 36, 36' and 36" to re ⁇ spective inlet pump fittings 32, 32' and 32" are preferably of the same length.
- each set of inlet and exit pump fittings are either numerically, color or otherwise coded to correspond to a respective coded operative position to provide proper orientation of the de- vice 10.
- the common junction block 20 is best seen in Fig. 3.
- the block 20 includes a junction body 54, a top cap 56 and a membrane 58 therebetween.
- the body 54 provides substantially parallel, vertical- ly spaced tapered channels 60, 60' and 60" which are each adapted to receive a respective fluid line 42, 42' and 42" so as not to inhibit fluid flow therethrough by crimping of the lines.
- the channels 60, 60' and 60" are tapered to provide a snug fit for fluid lines 42, 42' and 42" which are sealingly connected therein.
- Ports 62, 62* and 62" provide fluid communication between a respec ⁇ tive channel and a small volume chamber 64.
- the chamber 64 is at substantially right angles to the channels and ports and is of an inverted truncated cone shape 66 leading into another more pronounced inverted truncated cone shape 68 leading into a cylindrical portion 70.
- the top cap 56 is sealed, such as by welding, to the upper portion of the body 54 and secures the membrane 58 therebetween.
- the top cap 56 pro ⁇ vides a dish shaped opening 72 leading in a chan ⁇ nel 74 which provides communication with the mem ⁇ brane 58.
- the membrane 58 has a normally closed, resiliently deformable slit 76 which extends therethrough.
- the slit 76 provides a sealed ster ⁇ ile fluid path for the entrance of a * fluid connec ⁇ tor or the like to provide a fluid path to the re ⁇ DCving container. This is accomplished by the membrane 58 deforming and closing about the con ⁇ nector.
- top cap, membrane and slit are of the type disclosed in United States Patent No. 4,197,848 which issued in the names of Scott T. Garrett, Robert R. Fasana and William L. Rudzena
- a closure or dust cover 78 is provided to protect the fluid path of device 10 when not in use.
- the cover 78 includes a closure member 80, a connecting member 82 and a flexible arm 84 there ⁇ between.
- the connecting member 82 is ring-like and fits around the periphery of the upper end portion of the junction body 54.
- the top cap 56 is provided with a lip 86 at its upper end portion to prevent the member 82 from becoming dislodged from the junction body 54 and to provide a sealed connection with member 80.
- the flexible arm 84 connects the connecting member 82 and the closure member 80.
- the arm 84 maintains the members 80 and 82 in the substan ⁇ tially same plane and out of the way of the func ⁇ tional area when not used to protect device 10, but allows easy access when needed.
- the closure member 80 includes lip 88 and undercut 90 which are complemental with lip 86 of the top cap 56 to provide a sealed enclosure about the top cap 56 thereby protecting the fluid path of device 10.
- the member 80 is orientated with its internal side 92 facing downward, when not used to protect device 10, to prevent any particu- late matter from accumulating thereon.
- the member 80 when sealingly covering top cap 56 requires the flexible arm 84 to be rotated or twisted about its axis to provide the proper orientation of the clo ⁇ sure 80 with respect to the top cap 56.
- the mem ⁇ ber 80 also includes a pull tab 94 with a raised gripping area 96 for easy grasping of the tab 94 to facilitate the uncovering of the top cap 56.
- the device 10 of the present invention here- inabove described provides a unitized, sterile, economical fluid path between a plurality of solu ⁇ tion containers containing solutions to be trans ⁇ ferred to a receiving container.
- the device is especially adapted for use with the HIGH SPEED
- the device 10 provides the proper orienta ⁇ tion of the device with respect to the compounder to prevent errors.
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
- Executing Machine-Instructions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Dispositif stérile, uni et économique réalisant un chemin de fluide entre une pluralité de solutions (12, 14, 16) à mélanger et un récipient récepteur (18). Le dispositif comprend une pluralité de connecteurs de fluide et de conduites de fluide reliées de manière étanche aux ajustages respectifs de pompe, ce qui permet d'obtenir des chemins individuels jusqu'à un bloc commun de raccordement (20). Le bloc commun de raccordement (20) comprend une partie (60) recevant les conduites de fluide et les empêchant de friser de manière à maintenir l'écoulement du fluide. Le bloc (20) comprend également un orifice de sortie (76) réalisant un raccordement stérile étanche avec le récipient récepteur (18). Une fermeture (78) est également prévue pour protéger l'orifice de sortie (76) de toute contamination lorsque l'orifice (76) n'est pas en communication fluide avec le récipient récepteur (18).Sterile, plain and economical device providing a fluid path between a plurality of solutions (12, 14, 16) to be mixed and a receiving container (18). The device includes a plurality of fluid connectors and fluid lines which are tightly connected to the respective pump fittings, thereby providing individual paths to a common connection block (20). The common connection block (20) comprises a part (60) receiving the fluid lines and preventing them from curling so as to maintain the flow of the fluid. The block (20) also includes an outlet orifice (76) providing a sealed sterile connection with the receiving container (18). A closure (78) is also provided to protect the outlet orifice (76) from contamination when the orifice (76) is not in fluid communication with the receiving container (18).
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39178482A | 1982-06-24 | 1982-06-24 | |
US391784 | 1982-06-24 | ||
PCT/US1983/000678 WO1984000137A1 (en) | 1982-06-24 | 1983-05-09 | Fluid communication device |
Publications (4)
Publication Number | Publication Date |
---|---|
EP0112356A1 true EP0112356A1 (en) | 1984-07-04 |
EP0112356A4 EP0112356A4 (en) | 1985-09-09 |
EP0112356B1 EP0112356B1 (en) | 1988-08-31 |
EP0112356B2 EP0112356B2 (en) | 1995-12-27 |
Family
ID=23547936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP83902012A Expired - Lifetime EP0112356B2 (en) | 1982-06-24 | 1983-05-09 | Fluid communication device |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0112356B2 (en) |
AU (1) | AU557821B2 (en) |
DE (1) | DE3377867D1 (en) |
NO (1) | NO840664L (en) |
WO (1) | WO1984000137A1 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4718467A (en) * | 1986-05-30 | 1988-01-12 | Baxter Travenol Laboratories, Inc. | Pumping module arrangement and manifold |
US5334182A (en) * | 1992-09-02 | 1994-08-02 | Perry Creek Group Corporation | Pulmonary artery catheter monitoring bridge |
AU2012230767A1 (en) | 2011-03-23 | 2013-10-31 | Nxstage Medical, Inc. | Peritoneal dialysis systems, devices, and methods |
WO2017158032A1 (en) * | 2016-03-15 | 2017-09-21 | Fresenius Kabi Deutschland Gmbh | Method for the synthesis of a medical preparation |
WO2018237375A1 (en) | 2017-06-24 | 2018-12-27 | Nxstage Medical, Inc. | Peritoneal dialysis fluid preparation and/or treatment devices methods and systems |
US11872337B2 (en) | 2018-02-28 | 2024-01-16 | Nxstage Medical, Inc. | Fluid preparation and treatment devices methods and systems |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2814404A (en) * | 1953-12-02 | 1957-11-26 | Bryant W Griffin | Closure for beaded containers |
US4184815A (en) * | 1977-03-14 | 1980-01-22 | Extracorporeal Medical Specialties, Inc. | Roller pump rotor with integral spring arms |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB695403A (en) * | 1950-03-06 | 1953-08-12 | Fritz Heinemann | Improvements in or relating to closures for containers |
US3566930A (en) * | 1968-05-02 | 1971-03-02 | K N Enterprises Inc | Means for sterilely transferring blood plasma, serum, biological or pharmaceutical fluids, and the like |
US3565286A (en) * | 1968-10-18 | 1971-02-23 | Cryogenic Technology Inc | Liquid programming and pumping apparatus |
US3749285A (en) * | 1971-09-13 | 1973-07-31 | Haemonetics Corp | Programmed liquid delivery system |
US4006847A (en) * | 1975-10-23 | 1977-02-08 | Dooley Dynamics, Inc. | Dispensing apparatus |
US4143853A (en) * | 1977-07-14 | 1979-03-13 | Metatech Corporation | Valve for use with a catheter or the like |
US4191183A (en) * | 1977-10-31 | 1980-03-04 | Barry Mendelson | Mixing chamber for use in plural medical liquid intravenous administration set |
US4197848A (en) * | 1978-01-06 | 1980-04-15 | Baxter Travenol Laboratories, Inc. | Closed urinary irrigation site |
US4347874A (en) * | 1980-10-02 | 1982-09-07 | Sullivan James J | High speed sterile fluid transfer unit |
-
1983
- 1983-05-09 AU AU17027/83A patent/AU557821B2/en not_active Ceased
- 1983-05-09 DE DE8383902012T patent/DE3377867D1/en not_active Expired
- 1983-05-09 WO PCT/US1983/000678 patent/WO1984000137A1/en active IP Right Grant
- 1983-05-09 EP EP83902012A patent/EP0112356B2/en not_active Expired - Lifetime
-
1984
- 1984-02-22 NO NO840664A patent/NO840664L/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2814404A (en) * | 1953-12-02 | 1957-11-26 | Bryant W Griffin | Closure for beaded containers |
US4184815A (en) * | 1977-03-14 | 1980-01-22 | Extracorporeal Medical Specialties, Inc. | Roller pump rotor with integral spring arms |
Non-Patent Citations (1)
Title |
---|
See also references of WO8400137A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU557821B2 (en) | 1987-01-08 |
WO1984000137A1 (en) | 1984-01-19 |
DE3377867D1 (en) | 1988-10-06 |
EP0112356B1 (en) | 1988-08-31 |
NO840664L (en) | 1984-02-22 |
AU1702783A (en) | 1984-01-26 |
EP0112356A4 (en) | 1985-09-09 |
EP0112356B2 (en) | 1995-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4823833A (en) | Fluid communication device | |
US4372100A (en) | Process and apparatus for compounding hyperalimentation solutions | |
US4360435A (en) | Process for sterilizing and transferring a solution | |
CN103200895B (en) | Aseptic dispenser | |
US4750643A (en) | Sterile fluid dispensing system and method | |
US6032543A (en) | Device for introduction and/or withdrawal of a medium into/from a container | |
US8029023B2 (en) | Device and method for contamination-free and/or sterile sealing between at least two interconnectable connecting means | |
EP0948371B1 (en) | Apparatus for administrating toxic fluid | |
US6539248B1 (en) | Dye management system including an administration set with an in line burette | |
US4754786A (en) | Sterile fluid storage and dispensing apparatus and method for filling same | |
US3566930A (en) | Means for sterilely transferring blood plasma, serum, biological or pharmaceutical fluids, and the like | |
US4734091A (en) | Filtered manifold apparatus and method for ophthalmic irrigation | |
US20170042767A1 (en) | Needle holder for a vial | |
KR20180100233A (en) | Sterilization solution product bag | |
JP2011525142A (en) | System for dispensing fluids in an uncontrolled environment | |
AU557821B2 (en) | Fluid communication device | |
US5069370A (en) | Large scale liquid media dispensing and supplementing system | |
US20060231139A1 (en) | Method and disposable device for sampling and distributing a liquid, for example, in sterile conditions | |
EP0750488B1 (en) | A device and a process for aseptic mixing of liquid products | |
JPH0414029B2 (en) | ||
AU6484180A (en) | Process and apparatus for transferring and sterilizing a solution | |
EP0285116A2 (en) | Apparatus and process for testing the sterility of liquids and substances transferred in a liquid phase by the membrane filtering method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19840306 |
|
AK | Designated contracting states |
Designated state(s): BE CH DE FR GB LI SE |
|
17Q | First examination report despatched |
Effective date: 19860128 |
|
D17Q | First examination report despatched (deleted) | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): BE CH DE FR GB LI SE |
|
REF | Corresponds to: |
Ref document number: 3377867 Country of ref document: DE Date of ref document: 19881006 |
|
ET | Fr: translation filed | ||
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
26 | Opposition filed |
Opponent name: FRESENIUS AG Effective date: 19890530 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Free format text: BAXTER INTERNATIONAL INC. |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: CLINTEC NUTRITION COMPANY |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19940317 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19940321 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19940322 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19940324 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 19940415 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19940630 Year of fee payment: 12 |
|
EAL | Se: european patent in force in sweden |
Ref document number: 83902012.0 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Effective date: 19950509 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19950510 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Effective date: 19950531 Ref country code: CH Effective date: 19950531 Ref country code: BE Effective date: 19950531 |
|
PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
BERE | Be: lapsed |
Owner name: CLINTEC NUTRITION CY Effective date: 19950531 |
|
27A | Patent maintained in amended form |
Effective date: 19951227 |
|
AK | Designated contracting states |
Kind code of ref document: B2 Designated state(s): BE CH DE FR GB LI SE |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19950509 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: AEN Free format text: MAINTIEN DU BREVET DONT L'ETENDUE A ETE MODIFIEE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Effective date: 19960201 |
|
EUG | Se: european patent has lapsed |
Ref document number: 83902012.0 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Effective date: 19960229 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
EN | Fr: translation not filed | ||
APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |